Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer. Waterhouse D, Lam J, Betts KA, Yin L, et al. Lung Cancer 2021;156:41-49.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Waterhouse D, Lam J, Betts KA, Yin L, et al. Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer. Lung Cancer 2021;156:41-49.
PMID: 33894493